Search results
Showing 6811 to 6825 of 8218 results
Interventional procedures, IPG228 - Issued: August 2007 --> This guidance has been updated and replaced by NICE interventional procedures guidance 639.
Interventional procedures, IPG235 - Issued: October 2007 --> This guidance has been updated and replaced by NICE interventional procedures guidance 628.
Transcranial magnetic stimulation for severe depression (IPG242)
Interventional procedures, IPG242 - Issued: November 2007 --> This guidance has been updated and replaced by NICE interventional procedure guidance 542.
Interventional procedures, IPG260 - Issued: May 2008 --> This guidance has been updated and replaced by NICE interventional procedures guidance 591.
Electrically-stimulated intravesical chemotherapy for superficial bladder cancer (IPG277)
Interventional procedures, IPG277 - Issued: November 2008 --> This guidance has been updated and replaced by NICE interventional procedures guidance 638.
Customised titanium implants for orofacial reconstruction (IPG28)
Interventional procedures, IPG28 - Issued: December 2003 --> This guidance has been replaced by NICE interventional procedure guidance 457 and NICE interventional procedure guidance 449.
Infracoccygeal sacropexy using mesh for uterine prolapse repair (IPG280)
Interventional procedures, IPG280 - Issued: January 2009 --> This guidance has been updated and replaced by NICE interventional procedures guidance 582.
Interventional procedures, IPG282 - Issued: January 2009 --> This guidance has been updated and replaced by NICE interventional procedures guidance 584.
Systemic juvenile idiopathic arthritis: canakinumab (ESNM36)
This evidence summary has been withdrawn. An NHS England clinical commissioning policy statement on biologic therapies for the treatment of juvenile idiopathic arthritis is available.
Long-acting reversible contraception: levonorgestrel 13.5 mg intrauterine delivery system (ESNM41)
This evidence summary has been replaced by the long-acting reversible contraception: implementation resource summary.
Critical limb ischaemia in peripheral vascular disease: intravenous iloprost (ESUOM24)
April 2019: This evidence summary has been withdrawn because a product containing intravenous iloprost with a marketing authorisation for treating critical limb ischaemia in peripheral vascular disease is now available in the UK.
November 2024: This evidence summary has been withdrawn because licensed products are now available.
Daylight for treating generalised anxiety disorder in adults (MIB309)
August 2023: This medtech innovation briefing (MIB) has been withdrawn at the company’s request as the evidence for the technology has moved on and the company expect to seek a NICE guidance output in due course.
Ventripoint Medical System Plus for measuring heart volume and function (MIB310)
February 2023: The medtech innovation briefing on Ventripoint Medical System Plus for measuring heart volume and function has been withdrawn as the company have withdrawn from the process.
This medtech innovation briefing has been updated and replaced by NICE's early value assessment guidance on Genedrive MT-RNR1 ID Kit for detecting a genetic variant to guide antibiotic use and prevent hearing loss in babies.